Literature DB >> 28701336

Internet-based cognitive behavioural therapy for young people with suicide-related behaviour (Reframe-IT): a randomised controlled trial.

Sarah E Hetrick1,2, Hok P Yuen1,2, Eleanor Bailey1,2, Georgina R Cox1,2, Kate Templer1,2, Simon M Rice1,2,3, Sarah Bendall1,2, Jo Robinson1,2.   

Abstract

BACKGROUND: Suicide-related behaviours are common in young people and associated with a range of negative outcomes. There are few evidence-based interventions; however, cognitive behavioural therapy (CBT) shows promise. Internet delivery of CBT is popular, with potential to increase reach and accessibility.
OBJECTIVE: To test the effectiveness of an internet-based CBT program (Reframe-IT) in reducing suicide-related behaviours, depression, anxiety, hopelessness and improving problem solving and cognitive and behavioural skills in school students with suicide-related behaviours.
METHODS: A parallel randomised controlled trial testing the effectiveness of Reframe-IT plus treatment as usual (TAU) compared with TAU alone in reducing suicidal ideation, suicide attempts, depression, hopelessness, symptoms of anxiety, negative problem orientation and cognitive and behavioural skill acquisition was undertaken. We recruited students experiencing suicidal ideation from 18 schools in Melbourne, Australia, between August 2013 and December 2016. The intervention comprised eight modules of CBT delivered online over 10 weeks with assessments conducted at baseline, 10 weeks and 22 weeks.
FINDINGS: Only 50 of the planned 169 participants were recruited. There were larger improvements in the Reframe-IT group compared with the TAU group for the primary outcome of suicidal ideation (intervention -61.6, SD 41.6; control -47.1, SD 42.3, from baseline to 22-week follow-up intervention); however, differences were non-significant (p=0.593). There were no increases in distress in the majority of participants (91.1%) after completion of each module. Changes in depression and hopelessness partly mediated the effect of acquisition of CBT skills on suicidal ideation.
CONCLUSIONS: The trial was underpowered due to difficulties recruiting participants as a result of the complex recruitment procedures that were used to ensure safety of participants. Although there were no significant differences between groups, young people were safely and generally well engaged in Reframe-IT and experienced decreases in suicidal ideation and other symptoms as well as improvements in CBT skills. The study is the first online intervention trial internationally to include young people demonstrating all levels of suicide risk. CLINICAL IMPLICATIONS: Integration of internet-delivered interventions for young people with suicide-related behaviour may result in reductions in these behaviours. Further research is needed, but researchers should feel more confident about being able to safely undertake research with young people who experience these behaviours. TRIAL REGISTRATION NUMBER: ACTRN12613000864729. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  mental health

Mesh:

Year:  2017        PMID: 28701336     DOI: 10.1136/eb-2017-102719

Source DB:  PubMed          Journal:  Evid Based Ment Health        ISSN: 1362-0347


  24 in total

1.  Adaptation of evidence-based suicide prevention strategies during and after the COVID-19 pandemic.

Authors:  Danuta Wasserman; Miriam Iosue; Anika Wuestefeld; Vladimir Carli
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

Review 2.  Evidence-Based Interventions for Youth Suicide Risk.

Authors:  Danielle R Busby; Claire Hatkevich; Taylor C McGuire; Cheryl A King
Journal:  Curr Psychiatry Rep       Date:  2020-01-18       Impact factor: 5.285

3.  Evidence Base Update of Psychosocial Treatments for Self-Injurious Thoughts and Behaviors in Youth.

Authors:  Catherine R Glenn; Erika C Esposito; Andrew C Porter; Devin J Robinson
Journal:  J Clin Child Adolesc Psychol       Date:  2019-05-02

4.  What Works in Youth Suicide Prevention? A Systematic Review and Meta-Analysis.

Authors:  Jo Robinson; Eleanor Bailey; Katrina Witt; Nina Stefanac; Allison Milner; Dianne Currier; Jane Pirkis; Patrick Condron; Sarah Hetrick
Journal:  EClinicalMedicine       Date:  2018-10-28

5.  Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review.

Authors:  J John Mann; Christina A Michel; Randy P Auerbach
Journal:  Am J Psychiatry       Date:  2021-02-18       Impact factor: 19.242

6.  Ethical issues and practical barriers in internet-based suicide prevention research: a review and investigator survey.

Authors:  Eleanor Bailey; Charlotte Mühlmann; Simon Rice; Maja Nedeljkovic; Mario Alvarez-Jimenez; Lasse Sander; Alison L Calear; Philip J Batterham; Jo Robinson
Journal:  BMC Med Ethics       Date:  2020-05-13       Impact factor: 2.652

7.  Looking to the Future: A Synthesis of New Developments and Challenges in Suicide Research and Prevention.

Authors:  Rory C O'Connor; Gwendolyn Portzky
Journal:  Front Psychol       Date:  2018-11-27

8.  A Systematic Review of the Evidence Supporting Mobile- and Internet-Based Psychological Interventions For Self-Harm.

Authors:  Usman Arshad; Jessica Gauntlett; Nusrat Husain; Nasim Chaudhry; Peter James Taylor
Journal:  Suicide Life Threat Behav       Date:  2019-08-26

9.  Risk of repetition and subsequent self-harm following presentation to hospital with suicidal ideation: A longitudinal registry study.

Authors:  E Griffin; K Kavalidou; B Bonner; D O'Hagan; P Corcoran
Journal:  EClinicalMedicine       Date:  2020-06-05

10.  Extending research on Emotion Regulation Individual Therapy for Adolescents (ERITA) with nonsuicidal self-injury disorder: open pilot trial and mediation analysis of a novel online version.

Authors:  Johan Bjureberg; Hanna Sahlin; Erik Hedman-Lagerlöf; Kim L Gratz; Matthew T Tull; Jussi Jokinen; Clara Hellner; Brjánn Ljótsson
Journal:  BMC Psychiatry       Date:  2018-10-11       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.